Wojcicki’s Nonprofit Faces Legal Challenge in 23andMe Bid

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the bankrupt genetic testing company after her nonprofit, TTAM Research Institute, won a reopened bidding process with a $305 million offer, surpassing Regeneron Pharmaceuticals' earlier bid. The deal, pending bankruptcy court approval at a hearing scheduled for June 17, 2025, comes amid heightened privacy concerns about the genetic data of more than 11 million customers. TTAM has pledged to uphold existing privacy policies, permit customers to delete their data, and establish a Consumer Privacy Advisory Board, while vowing not to sell genetic data in future bankruptcies without equivalent protections. The acquisition faces legal challenges, particularly a lawsuit brought by 28 state attorneys general, who argue that selling customer data without consent would violate privacy rights. Wojcicki emphasized transparency and individual choice in managing genetic data. The outcome of the court hearing will determine the future of 23andMe and its approach to consumer privacy.